However, more studies are needed to better understand a clinical significance of S100A8/S100A9 within the established multiple myeloma—myeloid–MK axis that may regulate megakaryopoiesis in patients with multiple myeloma. The gene discussed is S100A9; the disease is AL amyloidosis.